These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31481165)

  • 1. Magnetoencephalography applied to the study of Alzheimer's disease.
    López-Sanz D; Bruña R; de Frutos-Lucas J; Maestú F
    Prog Mol Biol Transl Sci; 2019; 165():25-61. PubMed ID: 31481165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease.
    Nakamura A; Cuesta P; Fernández A; Arahata Y; Iwata K; Kuratsubo I; Bundo M; Hattori H; Sakurai T; Fukuda K; Washimi Y; Endo H; Takeda A; Diers K; Bajo R; Maestú F; Ito K; Kato T
    Brain; 2018 May; 141(5):1470-1485. PubMed ID: 29522156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: The state of the art in resting-state magnetoencephalography.
    Engels MMA; van der Flier WM; Stam CJ; Hillebrand A; Scheltens P; van Straaten ECW
    Clin Neurophysiol; 2017 Aug; 128(8):1426-1437. PubMed ID: 28622527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons.
    Babiloni C; Blinowska K; Bonanni L; Cichocki A; De Haan W; Del Percio C; Dubois B; Escudero J; Fernández A; Frisoni G; Guntekin B; Hajos M; Hampel H; Ifeachor E; Kilborn K; Kumar S; Johnsen K; Johannsson M; Jeong J; LeBeau F; Lizio R; Lopes da Silva F; Maestú F; McGeown WJ; McKeith I; Moretti DV; Nobili F; Olichney J; Onofrj M; Palop JJ; Rowan M; Stocchi F; Struzik ZM; Tanila H; Teipel S; Taylor JP; Weiergräber M; Yener G; Young-Pearse T; Drinkenburg WH; Randall F
    Neurobiol Aging; 2020 Jan; 85():58-73. PubMed ID: 31739167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Magnetoencephalography in the Early Stages of Alzheimer's Disease.
    López-Sanz D; Serrano N; Maestú F
    Front Neurosci; 2018; 12():572. PubMed ID: 30158852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Magnetoencephalography in the Early Stages of Alzheimer Disease.
    Maestú F; Fernández A
    Neuroimaging Clin N Am; 2020 May; 30(2):217-227. PubMed ID: 32336408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network Disruption in the Preclinical Stages of Alzheimer's Disease: From Subjective Cognitive Decline to Mild Cognitive Impairment.
    López-Sanz D; Garcés P; Álvarez B; Delgado-Losada ML; López-Higes R; Maestú F
    Int J Neural Syst; 2017 Dec; 27(8):1750041. PubMed ID: 28958179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEG biomarker of Alzheimer's disease: Absence of a prefrontal generator during auditory sensory gating.
    Josef Golubic S; Aine CJ; Stephen JM; Adair JC; Knoefel JE; Supek S
    Hum Brain Mapp; 2017 Oct; 38(10):5180-5194. PubMed ID: 28714589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Resting State Functional Connectivity in Prodromal and Dementia Stages of Alzheimer's Disease.
    Teipel SJ; Metzger CD; Brosseron F; Buerger K; Brueggen K; Catak C; Diesing D; Dobisch L; Fliebach K; Franke C; Heneka MT; Kilimann I; Kofler B; Menne F; Peters O; Polcher A; Priller J; Schneider A; Spottke A; Spruth EJ; Thelen M; Thyrian RJ; Wagner M; Düzel E; Jessen F; Dyrba M;
    J Alzheimers Dis; 2018; 64(3):801-813. PubMed ID: 29914027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and tracking of Alzheimer's disease severity using resting-state magnetoencephalography.
    Verdoorn TA; McCarten JR; Arciniegas DB; Golden R; Moldauer L; Georgopoulos A; Lewis S; Cassano M; Hemmy L; Orr W; Rojas DC
    J Alzheimers Dis; 2011; 26 Suppl 3():239-55. PubMed ID: 21971464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study.
    Yu M; Engels MMA; Hillebrand A; van Straaten ECW; Gouw AA; Teunissen C; van der Flier WM; Scheltens P; Stam CJ
    Brain; 2017 May; 140(5):1466-1485. PubMed ID: 28334883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Review of Magnetoencephalography (MEG) Studies for Brain Functionality in Healthy Aging and Alzheimer's Disease (AD).
    Mandal PK; Banerjee A; Tripathi M; Sharma A
    Front Comput Neurosci; 2018; 12():60. PubMed ID: 30190674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEG spectral profile in Alzheimer's disease and mild cognitive impairment.
    Fernández A; Hornero R; Mayo A; Poza J; Gil-Gregorio P; Ortiz T
    Clin Neurophysiol; 2006 Feb; 117(2):306-14. PubMed ID: 16386951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of magnetoencephalography signals from Alzheimer's disease patients using granger causality.
    Juan-Cruz C; Gomez C; Poza J; Fernandez A; Hornero R
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():724-727. PubMed ID: 28268430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders.
    Stam CJ
    J Neurol Sci; 2010 Feb; 289(1-2):128-34. PubMed ID: 19729174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of functional brain networks in Alzheimer's disease: what can we learn from graph spectral analysis of resting-state magnetoencephalography?
    de Haan W; van der Flier WM; Wang H; Van Mieghem PF; Scheltens P; Stam CJ
    Brain Connect; 2012; 2(2):45-55. PubMed ID: 22480296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-site, multi-participant magnetoencephalography resting-state dataset to study dementia: The BioFIND dataset.
    Vaghari D; Bruna R; Hughes LE; Nesbitt D; Tibon R; Rowe JB; Maestu F; Henson RN
    Neuroimage; 2022 Sep; 258():119344. PubMed ID: 35660461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the disruptions of the neurophysiological organization in Alzheimer's disease: An integrative approach.
    Gutiérrez-de Pablo V; Poza J; Maturana-Candelas A; Rodríguez-González V; Tola-Arribas MÁ; Cano M; Hoshi H; Shigihara Y; Hornero R; Gómez C
    Comput Methods Programs Biomed; 2024 Jun; 250():108197. PubMed ID: 38688139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional connectivity changes in mild cognitive impairment: A meta-analysis of M/EEG studies.
    Buzi G; Fornari C; Perinelli A; Mazza V
    Clin Neurophysiol; 2023 Dec; 156():183-195. PubMed ID: 37967512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEG delta mapping along the healthy aging-Alzheimer's disease continuum: diagnostic implications.
    Fernández A; Turrero A; Zuluaga P; Gil-Gregorio P; del Pozo F; Maestu F; Moratti S
    J Alzheimers Dis; 2013; 35(3):495-507. PubMed ID: 23478303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.